All Stories

  1. Stressful life events, PTSD symptoms and mental health in people living with HIV
  2. Effect of digital intervention in the self-management of depressive symptoms: the MENTINA trial – a study protocol for a randomised controlled parallel-group trial
  3. Systematic review update of organisational-level mental health promotion interventions: evidence from healthcare, construction, and telework-based mobile work settings
  4. Resilience in Bipolar Disorder Compared to Clinical and Non‐Clinical Populations: A Systematic Review and Meta‐Analysis
  5. Are loneliness and social network size mediators between childhood adversity and depressive symptoms? A cross-sectional replication study in Ethiopia
  6. A comparative analysis of age of onset and associated factors in non-refugee immigrants versus native-born individuals with psychotic disorders
  7. Barriers and facilitators impacting the implementation of digital interventions targeted at mental health and musculoskeletal disorders in the workplace: a scoping review protocol
  8. Neurocognitive and psychosocial functioning profiles in bipolar disorder and comorbid attention deficit hyperactivity disorder: A systematic review and meta-analysis
  9. The study protocol of a double-blind randomized controlled trial of EMDR and multifocal transcranial current stimulation (MtCS) as augmentation strategy in patients with fibromyalgia
  10. EMDR therapy vs. supportive therapy as adjunctive treatment in trauma-exposed bipolar patients: A randomised controlled trial
  11. The impact of sex in the effectiveness of functional remediation in bipolar disorder
  12. Psychosis onset and psychological trauma: a comparative study between non-refugee immigrants and native-born individuals.
  13. Towards an assessment of psychosocial work factors in a multi-level mental health intervention in the workplace: results from the MENTUPP pilot-study
  14. ºCorrigendum: Augmentation of EMDR with Multifocal transcranial Current Stimulation (MtCS) in the treatment of fibromyalgia: study protocol of a double blind randomized controlled exploratory and pragmatic trial.
  15. Barriers and facilitators to implementing workplace interventions to promote mental health: qualitative evidence synthesis
  16. The effects of different types of organisational workplace mental health interventions on mental health and wellbeing in healthcare workers: a systematic review
  17. Comparison of male and female non-refugee immigrants with psychosis: clinical, sociodemographic, and migration-related differences and impact on stress
  18. Clinician treatment choices for post-traumatic stress disorder: ambassadors survey of psychiatrists in 39 European countries
  19. Adverse childhood experiences and clinical effects of transcranial direct current stimulation in major depressive disorder: Results from the DepressionDC trial
  20. Suicidal behaviors and adverse childhood experiences: A cross-diagnostic study in persistent depressive disorder and borderline personality disorder
  21. Implementing a complex mental health intervention in occupational settings: process evaluation of the MENTUPP pilot study
  22. Transdiagnostic analysis of adverse childhood experiences and their association with psychopathology–A TRANS-D conform study
  23. Effects of resilience and timing of adverse and adaptive experiences on interpersonal behavior: a transdiagnostic study in a clinical sample
  24. A comparison of PTSD and traumatic event rates in a clinical sample of non-refugee immigrants and native-born individuals with a psychotic disorder: a case-control study
  25. Correction: Outcome assessment of a complex mental health intervention in the workplace. Results from the MENTUPP pilot study
  26. Implementation and evaluation of a multi-level mental health promotion intervention for the workplace (MENTUPP): study protocol for a cluster randomised controlled trial
  27. Promoting employee wellbeing and preventing non-clinical mental health problems in the workplace: a preparatory consultation survey
  28. Loneliness is associated with retrospective self-reports of adverse childhood experiences – A replication study in Ethiopia
  29. Outcome assessment of a complex mental health intervention in the workplace. Results from the MENTUPP pilot study
  30. EMDR therapy vs. Supportive Therapy as adjunctive treatment in trauma-exposed bipolar patients: a randomized controlled trial.
  31. Developing a framework for evaluation: a Theory of Change for complex workplace mental health interventions
  32. A systematic review of digital interventions for smoking cessation in patients with serious mental illness
  33. Evidence for the effectiveness of interventions to reduce mental health related stigma in the workplace: a systematic review
  34. Traumatic stress symptoms among Spanish healthcare workers during the COVID-19 pandemic: a prospective study
  35. Prevalence of clozapine-induced sialorrhea and its effect on quality of life
  36. Prevalence and Characterization of Psychological Trauma in Patients with Fibromyalgia: A Cross-Sectional Study
  37. The effectiveness of organisational-level workplace mental health interventions on mental health and wellbeing in construction workers: A systematic review and recommended research agenda
  38. Corrigendum to “Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population” [J. Affect. Disord. 249 (2019) 199–207 (Apr 15)]
  39. High incidence of PTSD diagnosis and trauma-related symptoms in a trauma exposed bipolar I and II sample
  40. Psychological trauma as a transdiagnostic risk factor for mental disorder: an umbrella meta-analysis
  41. Suicidal behaviors are associated with loneliness and decrease during inpatient CBASP treatment for persistent depressive disorder
  42. A fair day's wage for a fair day's work
  43. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic
  44. Workplace interventions to reduce depression and anxiety in small and medium-sized enterprises: A systematic review
  45. Clinical Features, Neuropsychology and Neuroimaging in Bipolar and Borderline Personality Disorder: A Systematic Review of Cross-Diagnostic Studies
  46. Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder
  47. The Prevalence and Clinical and Sociodemographic Factors of Problem Online Gambling: A Systematic Review
  48. Augmentation of EMDR with multifocal transcranial current stimulation (MtCS) in the treatment of fibromyalgia: study protocol of a double-blind randomized controlled exploratory and pragmatic trial
  49. Evidence for implementation of interventions to promote mental health in the workplace: a systematic scoping review protocol
  50. Thirty-day suicidal thoughts and behaviours in the Spanish adult general population during the first wave of the Spain COVID-19 pandemic
  51. Evidence for Implementation of Interventions to Promote Mental Health in the Workplace: A Systematic Scoping Review Protocol
  52. EMDR Versus Treatment-as-Usual in Patients With Chronic Non-Malignant Pain: A Randomized Controlled Pilot Study
  53. Traumatic Events in Dual Disorders: Prevalence and Clinical Characteristics
  54. Corrigendum: A Multicenter Phase II RCT to Compare the Effectiveness of EMDR Versus TAU in Patients With a First-Episode Psychosis and Psychological Trauma: A Protocol Design
  55. A Multicenter Phase II RCT to Compare the Effectiveness of EMDR Versus TAU in Patients With a First-Episode Psychosis and Psychological Trauma: A Protocol Design
  56. The Current Status of EMDR Therapy Involving the Treatment of Complex Posttraumatic Stress Disorder
  57. The Status of EMDR Therapy in the Treatment of Posttraumatic Stress Disorder 30 Years After Its Introduction
  58. Theoretical Background and Clinical Aspects of the Use of EMDR in Patients With Bipolar Disorder
  59. Editorial: Present and Future of EMDR in Clinical Psychology and Psychotherapy
  60. A 12-month prospective study on the time to hospitalization and clinical management of a cohort of bipolar type I and schizoaffective bipolar patients
  61. Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population
  62. A Multicenter Phase II Rater-Blinded Randomized Controlled Trial to Compare the Effectiveness of Eye Movement Desensitization Reprocessing Therapy vs. Treatment as Usual in Patients With Substance Use Disorder and History of Psychological Trauma: A Stu...
  63. That which does not kill you-May afflict you? Psychological trauma in bipolar disorder
  64. Meta-analyses of cavum septum pellucidum in mood disorders in comparison with healthy controls or schizophrenia
  65. Cognitive Remediation Interventions in Schizoaffective Disorder: A Systematic Review
  66. How Does Eye Movement Desensitization and Reprocessing Therapy Work? A Systematic Review on Suggested Mechanisms of Action
  67. A Non-randomized Controlled Trial of EMDR on Affective Symptoms in Patients With Glioblastoma Multiforme
  68. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables
  69. Multimodal Brain Changes in First-Episode Mania: A Voxel-Based Morphometry, Functional Magnetic Resonance Imaging, and Connectivity Study
  70. Eye Movement Desensitization and Reprocessing and Slow Wave Sleep: A Putative Mechanism of Action
  71. Efficacy of Eye Movement Desensitization and Reprocessing in Children and Adolescent with Post-traumatic Stress Disorder: A Meta-Analysis of Randomized Controlled Trials
  72. EMDR beyond PTSD: A Systematic Literature Review
  73. Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial
  74. Impact of childhood trauma on cognitive profile in bipolar disorder
  75. Psychiatric and physical comorbidities and their impact on the course of bipolar disorder: A prospective, naturalistic 4-year follow-up study
  76. Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis
  77. Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial
  78. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study
  79. Meta-Analysis of the Risk of Subsequent Mood Episodes in Bipolar Disorder
  80. Structural and Functional Brain Correlates of Cognitive Impairment in Euthymic Patients with Bipolar Disorder
  81. Surface-based brain morphometry and diffusion tensor imaging in schizoaffective disorder
  82. Brain functional changes in first-degree relatives of patients with bipolar disorder: evidence for default mode network dysfunction
  83. Neuropsychological and neuroimaging underpinnings of schizoaffective disorder: a systematic review
  84. 25 años de Eye Movement Desensitization and Reprocessing: protocolo de aplicación, hipótesis de funcionamiento y revisión sistemática de su eficacia en el trastorno por estrés postraumático
  85. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome
  86. Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life
  87. Prevalence of cavum vergae in psychosis and mood spectrum disorders
  88. Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory
  89. Midline Brain Abnormalities Across Psychotic and Mood Disorders
  90. Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder
  91. Prevalence and impact of comorbid alcohol use disorder in bipolar disorder: A prospective follow-up study
  92. Successful treatment of hydroxyzine and dexclorfeniramine maleate in combination with electroconvulsive therapy in a neuroleptic malignant catatonia
  93. Transcultural adaption and validation of the Spanish version of the Bipolar Depression Rating Scale (BDRS-S)
  94. Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms
  95. Brain functional changes across the different phases of bipolar disorder
  96. The prevalence and effect of life events in 222 bipolar I and II patients: A prospective, naturalistic 4 year follow-up study
  97. Comparison of serum BDNF levels in deficit and nondeficit chronic schizophrenia and healthy controls
  98. Trait or state? A longitudinal neuropsychological evaluation and fMRI study in schizoaffective disorder
  99. Eye movement desensitization and reprocessing therapy in subsyndromal bipolar patients with a history of traumatic events: A randomized, controlled pilot-study
  100. Saving time and money: a validation of the self ratings on the prospective NIMH life-chart method (NIMH-LCM)
  101. A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients
  102. Structural Abnormalities in Schizophrenia: Further Evidence on the Key Role of the Anterior Cingulate Cortex
  103. Treatment adherence in bipolar I and schizoaffective disorder, bipolar type
  104. No effects of eye movements on the encoding of the visuospatial sketchpad and the phonological loop in healthy participants: Possible implications for eye movement desensitization and reprocessing therapy
  105. Efficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study
  106. Bipolar depressed patients show both failure to activate and failure to de-activate during performance of a working memory task
  107. Differenzialdiagnostik und Psychopharmakotherapie bipolarer Störungen
  108. Deeskalationstechniken und atypische Neuroleptika in der Behandlung der akuten Manie
  109. EMDR Therapy Modulates the Default Mode Network in a Subsyndromal, Traumatized Bipolar Patient
  110. Brain functional abnormality in schizo-affective disorder: an fMRI study
  111. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls – Corrigendum
  112. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls
  113. Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patients
  114. Six-month functional outcome of a bipolar disorder cohort in the context of a specialized-care program
  115. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients
  116. First-episode psychosis is characterized by failure of deactivation but not by hypo- or hyperfrontality
  117. Failure of de-activation in the medial frontal cortex in mania: evidence for default mode network dysfunction in the disorder
  118. Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder
  119. Lamotrigine: when and where does it act in affective disorders? A systematic review
  120. Abnormal temperament in patients with morbid obesity seeking surgical treatment
  121. An Investigation of Temperamental Traits in Patients With Somatoform Disorder: Do They Belong in the Affective Spectrum?
  122. An Investigation of Temperamental Traits in Patients With Somatoform Disorder: Do They Belong in the Affective Spectrum?
  123. Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology
  124. Predictores clínicos del funcionamiento interpersonal en pacientes bipolares
  125. Anticonvulsants in the treatment of aggression in the demented elderly: an update
  126. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor
  127. Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?
  128. Myoclonus Provoked by Lamotrigine in a Bipolar Patient
  129. Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects
  130. Antiepileptic Drugs and Mood Stability
  131. A 2-Year, Open-Label Pilot Study of Adjunctive Chromium in Patients With Treatment-Resistant Rapid-Cycling Bipolar Disorder
  132. Risperidone monotherapy in manic inpatients: An open label, multicentre trial
  133. An Exploratory Open Trial on Safety and Efficacy of the Anticonvulsant Retigabine in Acute Manic Patients
  134. Rezidivprophylaxe bipolarer Erkrankungen
  135. Zotepine loading in acute and severely manic patients: a pilot study
  136. Neurochemical Underpinnings in Bipolar Disorder and Epilepsy
  137. Antiepileptic Drugs in Mood-Disordered Patients
  138. Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine
  139. Caffeine has no effect on measures of cortical excitability
  140. EEG Abnormalities Under Treatment with Atypical Antipsychotics: Effects of Olanzapine and Amisulpride as Compared to Haloperidol
  141. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects
  142. The evolution of antiepileptic drugs for mood stabilization and their main mechanisms of action
  143. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design
  144. Clozapine as Add-On Medication in the Maintenance Treatment of Bipolar and Schizoaffective Disorders
  145. Clinical Relevance and Treatment Possibilities of Bipolar Rapid Cycling
  146. Klinische Relevanz und Behandlungsmöglichkeiten von Rapid Cycling bei Patienten mit bipolarer affektiver Störung
  147. Central pontine myelinolysis in a patient with anorexia nervosa
  148. Antimanic Efficacy of Topiramate in 11 Patients in an Open Trial With an On-Off-On Design
  149. Nichtletale Wirkung hochtoxischer Amitriptylin-Spiegel nach Suizidversuch
  150. Wirksamkeit, Verträglichkeit und Praktikabilität von Valproat-Miniretardtabletten bei bipolaren affektiven Störungen
  151. Dysregulation of ion fluxes in bipolar affective disorder
  152. Bupropion-induced isolated impairment of sensory trigeminal nerve function
  153. Psychopathological Changes Preceding Motor Symptoms in Huntington's Disease: A Report on Four Cases
  154. Adding Low-Dose Antidepressants to Interferon Alpha Treatment for Chronic Hepatitis C Improved Psychiatric Tolerability in a Patient with Schizoaffective Psychosis
  155. Tiagabine Appears Not to Be Efficacious in the Treatment of Acute Mania
  156. Intravenous Valproate Loading in Acutely Manic and Depressed Bipolar I Patients
  157. Elektrokonvulsionstherapie in der Behandlung der schweren Manie
  158. Treatment of tardive akathisia with clonidine: a case report
  159. Female Genital Disorder as Adverse Symptom of Lamotrigine Treatment